This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Christopher Yankaskas – Pioneering Cancer Prognosis
Introduction
Christopher Yankaskas, an inventive mind based in Baltimore, MD, has made significant contributions to the field of cancer research through his innovative work. His singular patent exemplifies a groundbreaking approach to the analysis of cell motility, with the potential to greatly enhance patient prognosis and treatment personalization.
Latest Patents
Christopher's notable patent is titled "Use of an integrated microfluidic chip for analysis of cell motility and prediction and prognosis of patient survival." This integrated apparatus allows for the identification of invasive tumor cells directly from a specimen. The methods derived from this invention enable healthcare providers to predict survivability and assess the risk of cancer recurrence after treatment. It also aids in determining the most effective chemotherapeutic or other therapies to inhibit tumor cell invasiveness, presenting a tailored approach to patient care.
Career Highlights
Yankaskas is affiliated with The Johns Hopkins University, a prestigious institution recognized for its commitment to research and innovation in the medical field. His work there reflects a dedication to improving cancer treatment outcomes through advanced technology and methodologies.
Collaborations
Throughout his career, Christopher has collaborated with notable colleagues such as Konstantinos Konstantopoulos and Colin Dowlin Paul. Together, they contribute to the collective goal of enhancing cancer research and patient care, fostering an environment of innovation and discovery.
Conclusion
Christopher Yankaskas stands as a testament to the impact of innovative thinking in healthcare. Through his patent, he offers hope for improved cancer prognosis and treatment, and his collaborations reflect the spirit of teamwork in scientific advancement. His work not only exemplifies individual brilliance but also contributes to the larger mission of evolving medical practices for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile